文献速递前列腺癌

根治性前列腺切除术后阳性切缘基因组前列腺评分与复发的关系

Association of Genomic Prostate Score at positive margin with recurrence after radical prostatectomy.
PubMed 文献 · BJU Int · 2024-07-02

研究在约翰斯·霍普金斯2008至2017年813例根治性前列腺切除术后切缘阳性患者中选取223例组成病例队列,其中203例可评估阳性切缘组织的17基因基因组前列腺评分(GPS)。多变量分析显示GPS每增加20单位与生化复发风险显著相关(HR 1.56,95%CI 1.11-2.19,P=0.011)。作者认为阳性切缘GPS有助于预后分层并为辅助治疗决策提供信息。

要点

  • 阳性切缘组织可评估17基因基因组前列腺评分(GPS),评分范围0至100,评分越高风险越高。
  • 单变量分析中GPS每增加20单位与生化复发风险接近三倍升高相关(HR 2.82,P<0.001)。
  • 校正年龄、种族、术后CAPRA评分、阳性切缘Grade Group及辅助放疗后,GPS仍与生化复发显著相关(HR 1.56每20单位,95%CI 1.11-2.19,P=0.011)。

核心结论

  • 阳性手术切缘处的基因组前列腺评分可能有助于预后分层,并为根治性前列腺切除术后辅助治疗的临床决策提供信息。

研究设计与样本

  • 针对生化复发结局设计的病例队列研究,从2008至2017年在约翰斯·霍普金斯接受根治性前列腺切除术的813例切缘阳性且临床资料可用的患者中选取223例,其中213例有可用组织和临床资料。

主要发现

  • 从阳性手术切缘邻近的福尔马林固定石蜡包埋肿瘤组织中提取RNA,203例患者GPS可评估,评分范围0至100,评分越高风险越高。
  • 单变量分析中,GPS每增加20单位与生化复发风险接近三倍升高相关(HR 2.82,P<0.001)。
  • 校正年龄、种族、术后CAPRA评分、阳性切缘Grade Group及辅助放疗的多变量Cox模型中,GPS与生化复发显著相关(HR 1.56每20单位,95%CI 1.11-2.19,P=0.011)。

临床怎么用

  • 作者认为阳性手术切缘处的GPS可能有助于预后分层,并为根治性前列腺切除术后辅助治疗的临床决策提供信息。

局限性

  • 研究受回顾性和单机构设计限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the utility of the 17-gene Genomic Prostate Score® (GPS; MDxHealth, Irvine, CA, USA) performed on prostate cancer at the positive margin of the radical prostatectomy (RP) for its association with risk of subsequent biochemical recurrence (BCR). PATIENTS AND METHODS: We designed a case-cohort for the outcome of BCR, selecting 223 from a cohort of 813 RP patients treated at Johns Hopkins from 2008 to 2017 with positive margins and available clinical data; of these, 213 had available tissue and clinical data. RNA was isolated from formalin-fixed paraffin-embedded tumour tissue adjacent to the positive surgical margin and the GPS was evaluable in 203 of these patients with a score ranging from 0 to 100, with higher scores indicating higher risk. All patients underwent RP with or without adjuvant radiation therapy (ART). The statistical analysis employed Cox proportional hazards regression models for outcome of BCR weighted for case-cohort design. RESULTS: In univariable analysis, every 20-unit increase in the GPS was associated with a nearly threefold increase in risk of BCR (hazard ratio [HR] per 20 units 2.82, P < 0.001). In a multivariable Cox model adjusted for age, race, Cancer of the Prostate Risk Assessment Postsurgical score, Grade Group at the positive margin, and ART, the GPS was significantly associated with BCR (HR 1.56 per 20 units; 95% confidence interval 1.11-2.19; P = 0.011). The study is limited by its retrospective and single institution design. CONCLUSIONS: The GPS at the positive surgical margin could help stratify prognosis and inform clinical decision-making regarding adjuvant therapy after RP.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Nourmohammadi Abadchi S, Salles DC, Flannery C, et al. Association of Genomic Prostate Score at positive margin with recurrence after radical prostatectomy. BJU Int. 2024. PMID: 38953550. doi:10.1111/bju.16445

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。